Can O6-alkylguanine-DNA alkyltransferase depletion enhance alkylator activity in the clinic?
Publication
, Journal Article
Friedman, HS
Published in: Clin Cancer Res
August 2000
Duke Scholars
Published In
Clin Cancer Res
ISSN
1078-0432
Publication Date
August 2000
Volume
6
Issue
8
Start / End Page
2967 / 2968
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- O(6)-Methylguanine-DNA Methyltransferase
- Humans
- Guanine
- Enzyme Inhibitors
- Enzyme Activation
- Drug Synergism
- Carmustine
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents, Alkylating
Citation
APA
Chicago
ICMJE
MLA
NLM
Friedman, H. S. (2000). Can O6-alkylguanine-DNA alkyltransferase depletion enhance alkylator activity in the clinic? Clin Cancer Res, 6(8), 2967–2968.
Friedman, H. S. “Can O6-alkylguanine-DNA alkyltransferase depletion enhance alkylator activity in the clinic?” Clin Cancer Res 6, no. 8 (August 2000): 2967–68.
Friedman HS. Can O6-alkylguanine-DNA alkyltransferase depletion enhance alkylator activity in the clinic? Clin Cancer Res. 2000 Aug;6(8):2967–8.
Friedman, H. S. “Can O6-alkylguanine-DNA alkyltransferase depletion enhance alkylator activity in the clinic?” Clin Cancer Res, vol. 6, no. 8, Aug. 2000, pp. 2967–68.
Friedman HS. Can O6-alkylguanine-DNA alkyltransferase depletion enhance alkylator activity in the clinic? Clin Cancer Res. 2000 Aug;6(8):2967–2968.
Published In
Clin Cancer Res
ISSN
1078-0432
Publication Date
August 2000
Volume
6
Issue
8
Start / End Page
2967 / 2968
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- O(6)-Methylguanine-DNA Methyltransferase
- Humans
- Guanine
- Enzyme Inhibitors
- Enzyme Activation
- Drug Synergism
- Carmustine
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents, Alkylating